HA
Hilal Ahmad Zargar
About Hilal Ahmad Zargar
Data last updated:
Hilal Ahmad Zargar is a Director at Robindro Pharma Private Limited (since 2024), Director at Weitz Formulations Private Limited (since 2018) and Director at Weitz Biosciences Private Limited (since 2009). The companies operate in Pharma and Trading.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Robindro Pharma Private Limited U46497JK2024PTC015604 | Director | 12 Feb 2024 | 2024 | Active | |
| Weitz Formulations Private Limited U74999DL2018PTC330826 | Director | 13 Mar 2018 | 2018 | Active | |
| Weitz Biosciences Private Limited U24233JK2009PTC003094 | Director | 23 Dec 2009 | 2009 | Active |
Board colleagues of Hilal Ahmad Zargar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kaiser | 10497015 | Robindro Pharma Private Limited | Director |
| Suhail Ahmad Kath | 08079288 | Weitz Formulations Private Limited | Director |
| Zaid Showkat | 08673959 | Weitz Formulations Private Limited | Director |
| Riyaz Ahmad Wani | 02508923 | Weitz Biosciences Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hilal Ahmad Zargar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hilal Ahmad Zargar
Hilal Ahmad Zargar currently holds 3 directorships: Robindro Pharma Private Limited (Director, since 12 Feb 2024); Weitz Formulations Private Limited (Director, since 13 Mar 2018); Weitz Biosciences Private Limited (Director, since 23 Dec 2009).
Hilal Ahmad Zargar was first appointed on 23 Dec 2009 as Director at Weitz Biosciences Private Limited. The most recent appointment on record is 12 Feb 2024 at Robindro Pharma Private Limited.
The current boards of Hilal Ahmad Zargar's companies include Kaiser (Robindro Pharma Private Limited), Suhail Ahmad Kath (Weitz Formulations Private Limited), Zaid Showkat (Weitz Formulations Private Limited), Riyaz Ahmad Wani (Weitz Biosciences Private Limited).